当前位置:首页 - 行情中心 - 艾德生物(300685) - 财务分析

艾德生物

(300685)

  

流通市值:86.09亿  总市值:87.17亿
流通股本:3.94亿   总股本:3.99亿

艾德生物(300685)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.74亿元,每股收益0.44元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益160667.03万元,未分配利润94621.74万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产176790.51万元,负债16123.48万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入707,591,539.73458,706,418.67195,164,302.8842,180,427.77
营业总成本522,953,544.65325,528,824.4138,543,662.14662,108,578.12
营业利润196,604,196.93144,958,657.1865,490,166.27287,662,630.92
利润总额193,559,329.38143,602,741.9465,377,093.82286,082,858.54
净利润173,733,402.19126,761,239.8757,317,259.24264,292,151.8
其他综合收益-300,612.36545,061.37-1,822,782.73
综合收益总额173,432,789.83127,306,301.2457,317,259.24266,114,934.53
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计1,426,795,195.981,353,540,049.441,306,200,106.031,285,141,149.89
非流动资产合计341,109,876.11357,920,119.76365,221,844.95365,783,760.73
资产总计1,767,905,072.091,711,460,169.21,671,421,950.981,650,924,910.62
流动负债合计102,119,289.0892,680,114.7864,782,610.0891,966,025.66
非流动负债合计59,115,529.3258,971,429.1361,912,805.7759,231,359.71
负债合计161,234,818.4151,651,543.91126,695,415.85151,197,385.37
归属于母公司股东权益合计1,606,670,253.691,559,808,625.291,544,726,535.131,499,727,525.25
股东权益合计1,606,670,253.691,559,808,625.291,544,726,535.131,499,727,525.25
负债和股东权益合计1,767,905,072.091,711,460,169.21,671,421,950.981,650,924,910.62
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计747,397,660.25495,124,721.87231,654,038.82794,307,952.71
经营活动现金流出小计532,147,747.7352,145,343.27164,095,031.86645,271,160.65
经营活动产生的现金流量净额215,249,912.55142,979,378.667,559,006.96149,036,792.06
投资活动现金流入小计456,108,397.39330,253,772.39106,429,457.87402,141,172.01
投资活动现金流出小计657,380,909.04433,508,330.96194,610,979.83442,340,764
投资活动产生的现金流量净额-201,272,511.65-103,254,558.57-88,181,521.96-40,199,591.99
筹资活动现金流入小计8,880,236.688,636,1302,095,421.0761,543,246.65
筹资活动现金流出小计82,060,458.2880,478,393.5715,487,429.03182,119,641.73
筹资活动产生的现金流量净额-73,180,221.6-71,842,263.57-13,392,007.96-120,576,395.08
汇率变动对现金及现金等价物的影响10,952,233.3316,073,402.24-3,781,766.4124,594,184.86
现金及现金等价物净增加额-48,250,587.37-16,044,041.3-37,796,289.3712,854,989.85
期末现金及现金等价物余额195,340,872.61227,547,418.68205,795,170.61243,591,459.98
TOP↑